Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2018-05-17 / Oncol Lett 2018 Jul;16(1):1348-1356Autologous tumor lysate-pulsed dendritic cell vaccination therapy after resection of stage IIA (T2N0, T3N0) esophageal cancer: An analysis of immunological responses.
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2018-01-26 / J Clin Oncol 36, 2018 (suppl 5S; abstr 96)Safety, efficacy, and immunogenicity of autologous tumor lysate-pulsed dendritic cell vaccination therapy after resection of stage IIA (T2N0, T3N0) esophageal cancer: A phase I trial.
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2017-02-23 / J Clin Oncol 35, 2017 (suppl 7S; abstract 153)A Dendritic Cell Vaccine Combined With Radiotherapy Activates the Specific Immune Response in Patients With Esophageal Cancer
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2017-02-01 / J. Immunother. 2017 Feb/Mar;40(2):71-76Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysis
/in Esophageal Carcinoma, Hyperthermia, International Publications /von 2017-01-25 / J Clin Pharm Ther 2017 Apr;42(2):155-164Regional hyperthermia combined with radiotherapy for esophageal squamous cell carcinoma with supraclavicular lymph node metastasis
/in Esophageal Carcinoma, Hyperthermia, International Publications /von 2017-01-17 / Oncotarget 2017 Jan;8(3):5339-5348Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers
/in Esophageal Carcinoma, Hyperthermia, International Publications, Uterine Cancer /von 2016-11-01 / Cell Rep 2016 11;17(6):1621-1631Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer
/in Esophageal Carcinoma, Hyperthermia, International Publications /von 2015-09-08 / Oncol. Rep. 2015 Nov;34(5):2656-64Hyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapy
/in Esophageal Carcinoma, Hyperthermia, International Publications /von 2015-04-01 / Anticancer Res. 2015 Apr;35(4):2299-303
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de